Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from PW Medtech Group Ltd. ( (HK:1358) ) is now available.
PW Medtech Group Ltd. announced the first quarterly financial results for its subsidiary, Sichuan Ruijian Medical, showing a significant revenue increase of 43.89% compared to the previous year. This growth is attributed to the subsidiary’s expansion in domestic and overseas markets, increased brand awareness, and heightened market competitiveness, indicating a positive impact on the company’s market positioning and stakeholder interests.
More about PW Medtech Group Ltd.
PW Medtech Group Ltd., incorporated in the Cayman Islands, primarily focuses on investment holding and is engaged in the R&D, manufacturing, and sales of advanced medical devices, including infusion sets, intravenous cannula products, insulin needles, blood purification devices, and regenerative medical biomaterials in China.
Average Trading Volume: 874,932
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$1.61B
Learn more about 1358 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue